Search results for "trials"

showing 10 items of 966 documents

Efficacy of non-surgical periodontal treatment on patients with coronary artery disease: a meta-analysis of randomized controlled trials

2022

Coronary artery disease (CAD) is defined as one of the most common cardiovascular diseases (CVDs). Periodontitis is one of the risk factors for CAD. PubMed, Embase and Cochrane Library databases were carefully and thoroughly retrieved until October 2021. On the basis of the inclusion and exclusion criteria, eligible articles were selected strictly to identify randomized controlled trials (RCTs). Using Cochran's Q statistic, Review Manager 5.4 and Stata 16, data were extracted, and a comprehensive analysis was carried out. Six RCTs of 619 patients were included in this study, including 360 in the intervention group (IG) and 259 in the control group (CG). Meta-analysis showed significant diff…

crohn's diseaseCholesterol HDLCoronary Artery DiseaseCholesterol LDLaphthous stomatitisC-Reactive ProteinOtorhinolaryngologyinflammatory bowel diseasesystemic extraintestinal manifestationsHumansSurgeryundeterminedGeneral DentistryUNESCO:CIENCIAS MÉDICASTriglyceridesulcerative colitisRandomized Controlled Trials as TopicMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Scheduling a cellular manufacturing system with GA

2002

The flexible manufacturing cell scheduling problem is considered with a multi-objective approach, pursuing together makespan minimisation and the in process job wait minimisation. The formulation of the scheduling problem is discussed, analysing how to generate well suited sequences, like generalised permutation sequences, and the proper construction of a JIT timing of activities. An evolutionary sequencing algorithm based on both classic genetic operators and hybrid operators is then proposed. The hybrid operators have been introduced to construct highly fit initial population, to perform periodically a local search on the population and to maintain enough genetical diversity in the actual…

education.field_of_studyMathematical optimizationScheduleJob shop schedulingbusiness.industryComputer scienceCellular manufacturingPopulationScheduling (production processes)Work in processHybrid algorithmMinimisation (clinical trials)Scheduling (computing)Production controlGenetic algorithmLocal search (optimization)businesseducation
researchProduct

Ecological momentary intervention to enhance emotion regulation in healthcare workers via smartphone: a randomized controlled trial protocol

2022

Abstract Background CUIDA-TE is an APP that offers transdiagnostic cognitive behavioral therapy focused on enhancing emotion regulation. As a novelty, it incorporates ecological momentary interventions (EMI), which can provide psychological support in real time, when suffering arises. The main goal of the study is to evaluate the efficacy of CUIDA-TE to improve emotion regulation in healthcare workers, a population that has been particularly emotionally impacted by the COVID-19 pandemic. Methods In this three-arm, randomized controlled trial (RCT) the study sample will be composed of a minimum of 174 healthcare workers. They will be randomly assigned to a 2-month EMI group (CUIDA-TE APP, n …

emotion regulationSARS-CoV-2Health PersonnelEmocionsCOVID-19CBTDBTTeràpia de la conductasmartphoneEmotional RegulationPsychiatry and Mental healthTreatment OutcometransdiagnosticHumansSmartphoneAPPRCThealth professionalinterventionRandomized Controlled Trials as Topicecological momentary interventionBMC Psychiatry
researchProduct

Palliative sedation in patients with advanced cancer followed at home: A systematic review

2011

Abstract Context Patients with advanced cancer who are near the end of life may experience intolerable suffering refractory to targeted palliative therapies. Palliative sedation (PS) is considered to be an effective treatment modality for these refractory symptoms when aggressive efforts fail to provide relief. Objectives The aim of this study was to systematically review articles regarding PS performed at home in patients with intractable symptoms. Methods Literature databases searched included MedLine, PubMed, and EMBASE. The text words and MeSH/EMTREE terms "home care" and "sedation" were used for electronic database searches. Results Six articles met the inclusion criteria for research …

end of lifemedicine.medical_specialtyPalliative careSedationMEDLINEPainContext (language use)Palliative sedationend of life; home care; Palliative sedation; Clinical Trials as Topic; Delirium; Dyspnea; Home Care Services; Humans; Hypnotics and Sedatives; Neoplasms; Pain; Retrospective Studies; Treatment Outcome; Palliative Care; Anesthesiology and Pain Medicine; Neurology (clinical); Nursing (all)2901 Nursing (miscellaneous)NeoplasmsmedicineHumansHypnotics and SedativesIntensive care medicineProspective cohort studyGeneral NursingNursing (all)2901 Nursing (miscellaneous)Retrospective StudiesClinical Trials as Topicbusiness.industryPalliative CareDeliriumRetrospective cohort studyHome Care ServicesDyspneaTreatment OutcomeAnesthesiology and Pain MedicineMeta-analysisMidazolamNeurology (clinical)medicine.symptombusinesshome caremedicine.drug
researchProduct

CEA vs CAS

2009

Objectives: Last years registered an increment in the number of endovascular procedures. Traditional carotid endoarterectomy (CEA) is the most performed surgical treatment for carotid stenosis. In symptomatic patients CEA reduces significantly absolute relative risk of stroke and death. In asymptomatic patients AHA guidelines recommend CEA for stenosis 60–99%, if the risk of perioperative stroke or death is <3%. According to 2007 Clinical Expert Consensus Document Carotid Artery Stenting (CAS) should be used in patients at high-risk for CEA or into controlled trials and Cochrane Database of Systematic Reviews does not support a widespread change in clinical practice away from recommending C…

endarterectomytrialsstentingcarotid artery diseaseSettore MED/22 - Chirurgia Vascolare
researchProduct

New antihyperglycaemic agents and cardiovascular disease: let's be optimistic.

2018

Cardiovascular disease (CVD) substantially increases mortality in diabetes mellitus. This narrative review highlights recent research on the putative associations between dipeptyl peptidase 4 inhibitors, glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium glucose co-transporter 2 inhibitors (SGLT-2is) and several cardiovascular risk factors.New antihyperglycaemic agents favourably modulate several CVD risk factors, including fasting and postprandial plasma glucose levels, body weight, blood pressure, lipids, microalbuminuria, nonalcoholic fatty liver disease, serum uric acid, and arterial stiffness. Liraglutide (in LEADER), semaglutide (in SUSTAIN-6), empagliflozin (in EMPA-REG …

endocrine systembusiness.industryMEDLINE030209 endocrinology & metabolismDisease030204 cardiovascular system & hematologyBioinformaticsmedicine.disease03 medical and health sciences0302 clinical medicineCardiovascular DiseasesRisk FactorsDiabetes mellitusMedicineHumansHypoglycemic AgentsNarrative reviewCardiology and Cardiovascular MedicinebusinessRandomized Controlled Trials as TopicCurrent opinion in cardiology
researchProduct

Review article: a comparison of glucagon-like peptides 1 and 2.

2013

Summary Background Recent advancements in understanding the roles and functions of glucagon-like peptide 1 (GLP-1) and 2 (GLP-2) have provided a basis for targeting these peptides in therapeutic strategies. Aim To summarise the preclinical and clinical research supporting the discovery of new therapeutic molecules targeting GLP-1 and GLP-2. Methods This review is based on a comprehensive PubMed search, representing literature published during the past 30 years related to GLP-1 and GLP-2. Results Although produced and secreted together primarily from L cells of the intestine in response to ingestion of nutrients, GLP-1 and GLP-2 exhibit distinctive biological functions that are governed by t…

endocrine systemmedia_common.quotation_subjectIncretinPharmacologyintestinal peptides GLP-1 GLP-2 incretin intestinal motilitySettore BIO/09 - FisiologiaIntestinal mucosaGlucagon-Like Peptide 1Glucagon-Like Peptide 2Receptors GlucagonAnimalsHumansMedicinePharmacology (medical)Molecular Targeted TherapyReceptormedia_commonClinical Trials as TopicHepatologybusiness.industrydigestive oral and skin physiologyGastroenterologyAppetiteReview articleDisease Models Animalmedicine.anatomical_structureGlucagon-Like PeptidesbusinessPancreashormones hormone substitutes and hormone antagonistsFunction (biology)
researchProduct

Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome

2008

BACKGROUND: Ovarian hyperstimulation syndrome (OHSS) typically occurs when ovaries are primed with FSH/ LH and subsequently exposed to hCG. The ultimate pathophysiological step underlying this clinical picture is increased vascular permeability (VP). METHODS: A search of the literature was carried out using PubMed and the authors’ files. RESULTS: In rodents and humans, the expression of vascular endothelial growth factor (VEGF) and VEGF receptor 2 (VEGFR-2) mRNA increases during ovarian stimulation. With the administration of hCG, the expression of each rises to a maximum. Expression of VEGF/VEGFR-2 mRNAs correlates with enhanced VP, with both peaking 48 h following an injection of hCG. Imm…

endocrine systemmedicine.medical_specialtyCabergolineIndolesOvarian hyperstimulation syndromeVascular permeabilityBiologyChorionic GonadotropinDopamine agonistCapillary PermeabilityOvarian Hyperstimulation Syndromechemistry.chemical_compoundInternal medicineCabergolinemedicineAnimalsHumansPyrrolesErgolinesPhosphorylationCells CulturedClinical Trials as TopicEstradiolVascular Endothelial Growth FactorsObstetrics and GynecologyEstrogensKinase insert domain receptormedicine.diseaseRatsVascular endothelial growth factorActin CytoskeletonVascular endothelial growth factor Amedicine.anatomical_structureEndocrinologyReproductive MedicinechemistryDopamine AgonistsReproductive Control AgentsFemaleCorpus luteumSignal Transductionmedicine.drugHuman Reproduction Update
researchProduct

Glucose lowering and anti-atherogenic effects of incretin-based therapies: GLP-1 analogues and DPP-4-inhibitors

2009

Type 2 diabetes is a chronic, progressive disease with a multi-faceted pathophysiology. Beyond the known defects of insulin resistance and beta-cell insufficiency, derangement of incretin hormones normally produced from the gut wall in response to food intake play an important role. In recent years, the 'incretin-based' therapies (IBTs) have been developed to address hyperglycemia through either mimicking the action of the endogenous incretin glucagon-like polypeptide (GLP-1) (GLP-1 receptor agonists) or by inhibiting the activity of the enzyme that degrades GLP-1 (the dipeptyl peptidase-4 inhibitors).We reviewed available evidence on the glucose lowering and anti-atherogenic effects of IBT…

endocrine systemmedicine.medical_specialtyDipeptidyl Peptidase 410265 Clinic for Endocrinology and DiabetologyIncretin610 Medicine & healthType 2 diabetesCarbohydrate metabolismIncretinsInsulin resistancecardiovascular risk diabetes DPP-4 inhibitors GLP-1 analoguesGlucagon-Like Peptide 1Risk FactorsInternal medicineDiabetes mellitusmedicineAnimalsHumans2736 Pharmacology (medical)Pharmacology (medical)Dipeptidyl peptidase-4PharmacologyClinical Trials as TopicDipeptidyl-Peptidase IV Inhibitorsbusiness.industrydigestive oral and skin physiologyGeneral MedicineAtherosclerosismedicine.diseaseGlucose3004 PharmacologyEndocrinologyPostprandialDiabetes Mellitus Type 2aterosclerosibusinesshormones hormone substitutes and hormone antagonistsHormoneExpert Opinion on Investigational Drugs
researchProduct

Epidemiologia del dolore

2005

epidmiologia del doloretrials cliniciricerca epidemiologica
researchProduct